Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 18Recruiting 10Terminated 6Active not recruiting 4Unknown 2Withdrawn 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 1841Neoplasms 1230Colorectal Neoplasms 1046Carcinoma, Non-Small-Cell Lung 996Stomach Neoplasms 787Carcinoma, Hepatocellular 780Lung Neoplasms 756Prostatic Neoplasms 682Pancreatic Neoplasms 567Rectal Neoplasms 444Colonic Neoplasms 401Neoplasm Metastasis 400Ovarian Neoplasms 399Uterine Cervical Neoplasms 395Recurrence 380Leukemia, Myeloid, Acute 367Esophageal Neoplasms 352Multiple Myeloma 340Lymphoma 330Head and Neck Neoplasms 326Melanoma 306Precursor Cell Lymphoblastic Leukemia-Lymphoma 288Brain Neoplasms 263Urinary Bladder Neoplasms 249Nasopharyngeal Carcinoma 221Liver Neoplasms 221Leukemia 217Lymphoma, Large B-Cell, Diffuse 213Polycystic Ovary Syndrome 206Squamous Cell Carcinoma of Head and Neck 200

Interventions

pembrolizumab 1palbociclib 1epacadostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Thymus Neoplasms × Clear all
NCT02364076 2019-12-13

Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma

Georgetown University

Phase 2 Unknown
45 enrolled 10 charts
Thoracic

Thymoma, Thymus Neoplasms

NCT03219554 2017-08-02

A Phase II Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumor

Samsung Medical Center

Phase 2 Unknown
33 enrolled

Thymus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡